Condition: Hemophilia B · Sponsor: Biocad
The goal of this multicenter, two-stage, open-label study is to investigate the safety, immunogenicity, and efficacy of ANB-002 in subjects with hemophilia В. The study will have a dose-escalation design with elements of phase I/II seamless adaptive design.
This description comes directly from the study's public registry record.
Anna Eremeeva, MD PhD · +7 (812) 380 49 34 · eremeevaav@biocad.ru
Always discuss trial participation with your own doctor first.
| Republican Scientific and Practical Center for Radiation Medicine and Human Ecology | Homyel, Belarus | Recruiting |
| Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology | Minsk, Belarus | Recruiting |
| State Autonomous Institution for Healthcare "Chelyabinsk Regional Clinical Hospital" | Chelyabinsk, Russia | Recruiting |
| State budgetary healthcare institution Leningrad Regional Clinical Hospital | Gatchina, Russia | Recruiting |
| Kuzbass Clinical Hospital named after S.V. Belyaev | Kemerovo, Russia | Recruiting |
| Federal State Budgetary Organization of Science "Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency" | Kirov, Russia | Recruiting |
| Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Clinical Diagnostics for Hematology and Hemostasis Disorders) | Moscow, Russia | Recruiting |
| Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Traumatology and Reconstructive and Restorative Orthopedics for Patients with Hemophilia) | Moscow, Russia | Recruiting |
| Federal Budgetary Institution "Moscow City Clinical Hospital named after S. P. Botkin" | Moscow, Russia | Recruiting |
| LLC "Medis" | Nizhny Novgorod, Russia | Recruiting |
| State Novosibirsk Regional Clinical Hospital | Novosibirsk, Russia | Recruiting |
| Russian Research Institute of Hematology and Transfusiology Federal State Institution of Federal Medical and Biological Agency | Saint Petersburg, Russia | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06120582